These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12220607)

  • 21. Males and females differ in response to opioid agonist medications.
    Jones HE; Fitzgerald H; Johnson RE
    Am J Addict; 2005; 14(3):223-33. PubMed ID: 16019973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion of substance abuse treatment: will buprenorphine be a success?
    Ling W; Cunningham-Rathner J; Rawson R
    J Psychoactive Drugs; 2004 May; Suppl 2():115-7. PubMed ID: 15279123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addiction pharmacotherapy 2000: new options, new challenges.
    Rawson RA; McCann MJ; Hasson AJ; Ling W
    J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LAAM maintenance vs methadone maintenance for heroin dependence.
    Clark N; Lintzeris N; Gijsbers A; Whelan G; Dunlop A; Ritter A; Ling W
    Cochrane Database Syst Rev; 2002; (2):CD002210. PubMed ID: 12076441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
    Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opiate maintenance alternatives: new studies.
    Harv Ment Health Lett; 2005 Sep; 22(3):6. PubMed ID: 16224834
    [No Abstract]   [Full Text] [Related]  

  • 27. Twenty years of the methadone treatment protocol in Ireland: reflections on the role of general practice.
    Delargy I; Crowley D; Van Hout MC
    Harm Reduct J; 2019 Jan; 16(1):5. PubMed ID: 30654803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Review of scientific evidence on alternatives to methadone in the psychopharmacologic treatment of opiate dependence].
    Iruín A; Aizpurua I; Ruiz de Apodaka J; Zapiraín E; Aizpuru A
    Rev Esp Salud Publica; 2001; 75(3):207-19. PubMed ID: 11515335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of opioid substitution therapy on alcohol metabolism.
    Clark NC; Dietze P; Lenné MG; Redman JR
    J Subst Abuse Treat; 2006 Apr; 30(3):191-6. PubMed ID: 16616162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.
    Simoens S; Matheson C; Bond C; Inkster K; Ludbrook A
    Br J Gen Pract; 2005 Feb; 55(511):139-46. PubMed ID: 15720937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
    Soyka M; Hillemacher T
    Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113
    [No Abstract]   [Full Text] [Related]  

  • 32. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of opioid dependence pharmacotherapies on zidovudine disposition.
    McCance-Katz EF; Rainey PM; Friedland G; Kosten TR; Jatlow P
    Am J Addict; 2001; 10(4):296-307. PubMed ID: 11783744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological advances in addiction treatment.
    Preston KL; Bigelow GE
    Int J Addict; 1985; 20(6-7):845-67. PubMed ID: 2867050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis.
    Chopra MP; Feldman Z; Mancino MJ; Oliveto A
    Pharmacol Biochem Behav; 2008 Oct; 90(4):787-96. PubMed ID: 18585405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence.
    Maas B; Kerr T; Fairbairn N; Montaner J; Wood E
    Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):533-43. PubMed ID: 16859402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence.
    Dean AJ; Bell J; Christie MJ; Mattick RP
    Eur Psychiatry; 2004 Dec; 19(8):510-3. PubMed ID: 15589713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.